Seeking Alpha

Big data the key to pharma cost savings

  • Big Pharma needs to cut $35B from its commercial operations over the next few years if it expects to maintain its current operating margin of ~25%.
  • Big data may be the way to do it by providing more-demanding payers with evidence that its products are delivering their expected cost benefits.
  • Better data analysis also promises to improve commercial operations by enabling more precise marketing.
  • According to a recent IHS Health survey, 40% of respondents expect to cut commercial operations at least 10% while a fifth foresee cuts of 15% or greater.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio: